Condition

Latrodectism (3)

Arachnidism (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

phase 3 (1)

Sponsor

Instituto Bioclon S.A. de C.V. (2)

Laboratorios Silanes S.A. de C.V. (1)

Collaborator

Rare Disease Therapeutics Inc. (2)

Rocky Mountain Poison and Drug Center (1)

Intervention

analatro (1)

anawidow [antivenin latrodectus (black widow) equine immune f(ab)2] lyophilized powder for solution 10 ml (1)

placebo (1)

saline (1)

widow spider antivenom (1)

Study Documents

Intervention Type

drug (2)

biological (1)

Funder Type

Industry (3)

Study Type

Interventional (3)

latrodectism

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Latrodectism Trial in Ciudad de mexico (ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder

Completed

Latrodectism

ANAWIDOW [antivenin latrodectus (black widow) equine immune F(ab)2] lyophilized powder for solution 10 mL

Ciudad de mexico, Mexico City, Mexico

Laboratorio Silanes, S.A. de C.V.

Feb 28, 2022

Latrodectism Trial in United States (Analatro, Saline)

Completed

Has Results

Latrodectism

Phoenix, Arizona
+15 more

Mar 7, 2018

Arachnidism, Latrodectism Trial in Denver (widow spider antivenom, Placebo)

Completed

Arachnidism
Latrodectism

widow spider antivenom
Placebo

Denver, Colorado

Denver Health and Hospital Authority

Mar 18, 2016